wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q33660069-0897530B-3220-4B96-BA74-5FD32FA25D1D
Q33660069-0897530B-3220-4B96-BA74-5FD32FA25D1D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33660069-0897530B-3220-4B96-BA74-5FD32FA25D1D
The innate and adaptive infiltrating immune systems as targets for breast cancer immunotherapy.
P2860
Q33660069-0897530B-3220-4B96-BA74-5FD32FA25D1D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33660069-0897530B-3220-4B96-BA74-5FD32FA25D1D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
da41d5234b5b4937c4f67a89a543bae7a99af4d1
P2860
The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study.